Zenas BioPharma, Inc.
4.79%
3,029,921
1953926
Mar 30, 2026
Apr 2, 2026, 05:44 PM
Reporting Persons (3)
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Leon O. Moulder, Jr. | Individual | 4.79% | 3,029,921 | 1,266,954 | 1,762,967 |
| Tellus BioVentures, LLC | Other | 2.77% | 1,726,039 | 0 | 1,726,039 |
| Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008 | Other | 0.06% | 36,928 | 0 | 36,928 |
Disclosure Items (3)
Common Stock, $0.0001 par value per share
Zenas BioPharma, Inc.
852 Winter Street, Waltham, MA, 02451
Item 3 of the Original Schedule 13D is hereby amended and supplemented by adding the following to the end of Item 3: On February 2, 2026, Mr. Moulder purchased 57,000 shares of Common Stock in multiple open-market transactions at prices per share ranging from $17.69 to $18.14, inclusive. Between March 30, 2026 and March 31, 2026, Tellus purchased 54,000 shares of Common Stock in multiple open-market transactions at prices per share ranging from $18.195 to $19.58, inclusive.
See Items 7-11 of the cover pages of this Statement.
See Items 7-11 of the cover pages of this Statement.
Except as reported in this Statement, no Reporting Person has effected any transactions in the Issuer's securities within the past 60 days.
Not applicable.
March 31, 2026